MAR 14, 2016 2:21 PM PDT

Functional Heart Muscle Regenerated Using Human Cells

WRITTEN BY: Julianne Chiaet
A partially recellularized human whole-heart cardiac scaffold, reseeded with human cardiomyocytes derived from induced pluripotent stem cells, being cultured in a bioreactor that delivers a nutrient solution and replicates some of the environmental conditions around a living heart. Researchers have developed functional heart tissue in a lab. Their work can be used to help grow heart tissue patches using the patient’s own cells. 

The Massachusetts General Hospital (MGH) scientists created the tissue using donor hearts stripped of components that would generate an immune response. They additionally used cardiac muscle cells generated from induced pluripotent stem cells. Pluripotent stem cells are cells taken from any tissue (usually the skin or blood) of a person and reengineered to behave like an embryonic stem cell. In this case, the pluripotent stem cells could be taken from a potential recipient. 

"Generating functional cardiac tissue involves meeting several challenges," said biomedical engineer Jacques Guyette, the lead author  of the paper. "These include providing a structural scaffold that is able to support cardiac function, a supply of specialized cardiac cells, and a supportive environment in which cells can repopulate the scaffold to form mature tissue capable of handling complex cardiac functions.”

The researchers grew a scaffold from proteins secreted by the cell to give the tissues shape. They used 73 donor hearts, deemed unfit for transplant, to create the tissue. Using a method invented by team leader Harald Ott in 2008, the scientists stripped living cells out of the donor organs (decellularization). They then repopulated the remaining extracellular matrix scaffold with organ-appropriate cell-types (recellularization). In this recellularization step, messenger RNA was used to regenerate skin cells back to stem cells. The resulting pluripotent stem cells were then programmed to grow cardiac muscle cells.

The organs were then mounted for 14 days in an automated bioreactor system the researchers previously developed. The automated bioreactor system has the ability to support a whole human heart during the recellularization process. 

The researchers’ method led to a high retention of matrix proteins and a structure without cardiac cells. The method also allowed for the preservation of coronary vascular and microvascular structures. 
 

Creating a bioengineered human heart is "most certainly a long-term goal that is several years away," says Guyette. "We are currently working on engineering a functional myocardial patch that could replace cardiac tissue damaged due a heart attack or heart failure."

"Among the next steps [include] improving methods to generate even more cardiac cells - recellularizing a whole heart would take tens of billions, optimizing bioreactor-based culture techniques to improve the maturation and function of engineered cardiac tissue, and electronically integrating regenerated tissue to function within the recipient's heart."

Ott adds that "generating personalized functional myocardium from patient-derived cells is an important step towards novel device-engineering strategies and will potentially enable patient-specific disease modeling and therapeutic discovery. Our team is excited to further develop both of these strategies in future projects."

The research was published on March 11, 2016, in the journal Circulation Research.

Sources: Massechussetts General Hospital press release via EurekAlert!, Circulation Research 
About the Author
  • Julianne (@JuliChiaet) covers health and medicine for LabRoots. Her work has been published in The Daily Beast, Scientific American, and MailOnline. While primarily a science journalist, she has also covered culture and Japanese organized crime. She is the New York Board Representative for the Asian American Journalists Association (AAJA). • To read more of her writing, or to send her a message, go to Jchiaet.com
You May Also Like
OCT 03, 2021
Health & Medicine
Why Did a Town Start Putting People on Trial for Witchcraft?
OCT 03, 2021
Why Did a Town Start Putting People on Trial for Witchcraft?
In early 1692 in Salem, Massachusetts, the daughter and niece of Reverend Samuel Parris began to writhe, roar, contort, ...
OCT 09, 2021
Health & Medicine
Akathisia Awareness: A Closer Look
OCT 09, 2021
Akathisia Awareness: A Closer Look
Content warning: this article talks in-depth about suicide and self-harm. September was Suicide Prevention Month, but ju ...
OCT 19, 2021
Immunology
Reverse Vaccinations Tame the Immune System to Help Hemophilia Patients
OCT 19, 2021
Reverse Vaccinations Tame the Immune System to Help Hemophilia Patients
In patients with hemophilia A—a hereditary disorder where the blood cannot clot properly—their immune system ...
OCT 21, 2021
Clinical & Molecular DX
Glucose Sensor Ditches the Enzymes
OCT 21, 2021
Glucose Sensor Ditches the Enzymes
A team of engineers has developed a wearable device that can monitor blood sugar levels minus the painful finger prick. ...
OCT 18, 2021
Health & Medicine
Emerging Research on Delta 8 THC
OCT 18, 2021
Emerging Research on Delta 8 THC
Delta-8-tetrahydrocannabinol is a cannabinoid derived from the hemp plant. It is one of the more prominent compounds, bu ...
OCT 19, 2021
Drug Discovery & Development
Researchers develop a potent antiviral drug for dengue fever
OCT 19, 2021
Researchers develop a potent antiviral drug for dengue fever
Dengue fever is a mosquito borne illness that is widespread, especially in tropical countries. The global incidence of d ...
Loading Comments...